Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05541055 · ClinicalTrials.gov registry record · NA
Digital CBT-I for Insomnia Disorder
A NA study, sponsored by Big Health.
- Completed
- Registry status
- NA
- Development phase
- 336
- Enrollment target
NCT05541055: Completed NA study, sponsored by Big Health.
NCT05541055 is a NA study that has completed, run by Big Health. The registered enrollment target is 336 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05541055, a NA study, has completed, sponsored by Big Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 336 participants
- Enrollment target
Study Summary
This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.
Primary Outcome
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Interventions
- DEVICE digital CBT-I
- OTHER Sleep hygiene education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
What the finished NCT05541055 record still lists
NCT05541055 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which digital CBT-I is the first listed.
NCT05541055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05541055 about?
NCT05541055 is a clinical study titled "Digital CBT-I for Insomnia Disorder". This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.
What is the current status of trial NCT05541055?
This trial is currently completed. It is a NA study. The enrollment target is 336 participants. The study started on 2022-11-08. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT05541055?
The interventions under investigation include: digital CBT-I (DEVICE), Sleep hygiene education (OTHER).
Who is sponsoring clinical trial NCT05541055?
This trial is sponsored by Big Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05541055's enrollment target sits among peer trials
336 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI